{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:09:22Z","timestamp":1785506962159,"version":"3.56.0"},"reference-count":47,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011705","name":"Ministry of Oceans and Fisheries","doi-asserted-by":"publisher","award":["RS-2022-KS221637"],"award-info":[{"award-number":["RS-2022-KS221637"]}],"id":[{"id":"10.13039\/501100011705","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mar. Drugs","Marine Drugs"],"abstract":"<jats:p>Chronic constipation is a prevalent functional gastrointestinal disorder with limited long-term treatment options. This study examined whether a fucoidan preparation derived from Sargassum fusiforme (SF) ameliorates loperamide (LOP)-induced constipation in male ICR mice. SF was administered by oral gavage at 50, 100 or 200 mg\/kg\/day for 35 days, and constipation was induced with LOP (5 mg\/kg) during the final 7 days; the design is therefore preventive rather than therapeutic. Defecation endpoints were recorded at the cage level (n = 3 cages per group) and fecal moisture in individual mice (n = 7 per group), whereas colonic cytokine and myeloperoxidase (MPO) measurements (n = 3\u20134 per group) and Western blot analyses (n = 3 per group) were performed in a small subset of animals, and histological analyses in n = 6\u20138 per group. SF increased fecal output and fecal moisture content with increasing dose; at 200 mg\/kg the relative fecal number returned to the level of the Vehicle control group, although the absolute daily pellet count remained lower than that of the Vehicle control and of the Positive control group. SF administration was associated with lower colonic TNF-\u03b1, IL-6, IL-1\u03b2 and MPO concentrations, with reduced phosphorylation of p38, JNK and ERK, with higher C-kit and stem cell factor (SCF) levels, with normalization of the LOP-induced increase in aquaporin-3 (AQP3), and with recovery of colonic mucosal thickness and mucin content. 16S rRNA gene sequencing showed a shift in fecal microbiota community structure (PERMANOVA p = 0.0002) and a dose-related increase in the combined relative abundance of Lactobacillus and Bifidobacterium, without a reduction in alpha diversity. These findings indicate that SF ameliorates LOP-induced constipation in male mice and that this effect is accompanied by changes in colonic inflammatory signaling, motility-related protein expression, mucosal architecture and gut microbiota composition.<\/jats:p>","DOI":"10.3390\/md24080266","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T13:23:20Z","timestamp":1785504200000},"page":"266","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Sargassum fusiforme-Derived Fucoidan Preparation Ameliorates Loperamide-Induced Constipation and Is Associated with Changes in Colonic Inflammation and Gut Microbiota in Mice"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5598-097X","authenticated-orcid":false,"given":"Jun-Geon","family":"Je","sequence":"first","affiliation":[{"name":"Department of Marine Life Sciences, Jeju National University, Jeju 63243, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan-Young","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Marine Life Sciences, Jeju National University, Jeju 63243, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Woon","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Marine Life Sciences, Jeju National University, Jeju 63243, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajasinghe Peli Gedara Sewwandi Kaushalya","family":"Amarasiri","sequence":"additional","affiliation":[{"name":"Department of Marine Life Sciences, Jeju National University, Jeju 63243, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimin","family":"Hyun","sequence":"additional","affiliation":[{"name":"Major of Food Science and Nutrition, Pukyong National University, Busan 48513, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bomi","family":"Ryu","sequence":"additional","affiliation":[{"name":"Major of Food Science and Nutrition, Pukyong National University, Busan 48513, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3299-7266","authenticated-orcid":false,"given":"You-Jin","family":"Jeon","sequence":"additional","affiliation":[{"name":"Department of Marine Life Sciences, Jeju National University, Jeju 63243, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Bischoff, S.C. (2011). \u2018Gut health\u2019: A new objective in medicine?. BMC Med., 9.","DOI":"10.1186\/1741-7015-9-24"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Wang, Q., Meng, Q., Chen, Y., Liu, Y., Li, X., Zhou, J., Ma, Y., Yu, Z., and Chen, X. (2025). Interaction between gut microbiota and immunity in health and intestinal disease. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1673852"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Munteanu, C., Turti, S., and Marza, S.M. (2025). Unraveling the Gut\u2013Skin Axis: The Role of Microbiota in Skin Health and Disease. Cosmetics, 12.","DOI":"10.3390\/cosmetics12040167"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/obr.12541","article-title":"Weight-loss interventions and gut microbiota changes in overweight and obese patients: A systematic review","volume":"18","author":"Seganfredo","year":"2017","journal-title":"Obes. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s41575-025-01077-5","article-title":"The gut microbiome connects nutrition and human health","volume":"22","author":"Sanz","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_6","first-page":"920","article-title":"Brain-gut-microbiota axis and mental health","volume":"79","author":"Dinan","year":"2017","journal-title":"Biopsychosoc. Sci. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"100106","DOI":"10.1016\/j.medmic.2024.100106","article-title":"Antibiotics and the gut microbiome: Understanding the impact on human health","volume":"20","author":"Lathakumari","year":"2024","journal-title":"Med. Microecol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41575-026-01176-x","article-title":"The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of gut health","volume":"23","author":"Marco","year":"2026","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","article-title":"Bowel disorders","volume":"150","author":"Lacy","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1053\/j.gastro.2022.12.009","article-title":"Negative impact of disorders of gut-brain interaction on health-related quality of life: Results from the Rome foundation global epidemiology survey","volume":"164","author":"Knowles","year":"2023","journal-title":"Gastroenterology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2360233","DOI":"10.1080\/19490976.2024.2360233","article-title":"The gut microbiome in disorders of gut\u2013brain interaction","volume":"16","author":"Kraimi","year":"2024","journal-title":"Gut Microbes"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","article-title":"Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation Global Study","volume":"160","author":"Sperber","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/ajg.2011.164","article-title":"Prevalence of, and risk factors for, chronic idiopathic constipation in the community: Systematic review and meta-analysis","volume":"106","author":"Suares","year":"2011","journal-title":"Off. J. Am. Coll. Gastroenterol. ACG"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e10631","DOI":"10.1097\/MD.0000000000010631","article-title":"Chronic constipation: A review of literature","volume":"97","author":"Forootan","year":"2018","journal-title":"Medicine"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1053\/j.gastro.2023.03.214","article-title":"American Gastroenterological Association-American College of Gastroenterology clinical practice guideline: Pharmacological management of chronic idiopathic constipation","volume":"164","author":"Chang","year":"2023","journal-title":"Gastroenterology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1365-2982.2011.01709.x","article-title":"Diagnosis and treatment of chronic constipation\u2013a European perspective","volume":"23","author":"Tack","year":"2011","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3945\/an.116.014407","article-title":"Mechanisms of action of probiotics and the gastrointestinal microbiota on gut motility and constipation","volume":"8","author":"Dimidi","year":"2017","journal-title":"Adv. Nutr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/gastro\/goab035","article-title":"Role of gut microbiota in functional constipation","volume":"9","author":"Zhang","year":"2021","journal-title":"Gastroenterol. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.4049\/jimmunol.168.10.5342","article-title":"p38 mitogen-activated protein kinase is activated and linked to TNF-\u03b1 signaling in inflammatory bowel disease","volume":"168","author":"Waetzig","year":"2002","journal-title":"J. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1053\/gast.2002.30770","article-title":"Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn\u2019s disease","volume":"122","author":"Hommes","year":"2002","journal-title":"Gastroenterology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00383-023-05467-1","article-title":"Interstitial cells of Cajal: Clinical relevance in pediatric gastrointestinal motility disorders","volume":"39","author":"Friedmacher","year":"2023","journal-title":"Pediatr. Surg. Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00000478-200302000-00012","article-title":"Loss of CD117 (c-kit)-and CD34-positive ICC and associated CD34-positive fibroblasts defines a subpopulation of chronic intestinal pseudo-obstruction","volume":"27","author":"Streutker","year":"2003","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Ikarashi, N., Kon, R., and Sugiyama, K. (2016). Aquaporins in the colon as a new therapeutic target in diarrhea and constipation. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17071172"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Shi, Y., Han, Y., Jiang, J., Wang, D., Li, Z., Sun, G., Wang, S., Liao, W., Xia, H., and Pan, D. (2025). Oat Fiber Alleviates Loperamide-Induced Constipation in Mice by Modulating Intestinal Barrier Function. Nutrients, 17.","DOI":"10.3390\/nu17152481"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11894-010-0131-2","article-title":"Intestinal goblet cells and mucins in health and disease: Recent insights and progress","volume":"12","author":"Kim","year":"2010","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.dld.2005.06.008","article-title":"Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation","volume":"37","author":"Khalif","year":"2005","journal-title":"Dig. Liver Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.carbpol.2010.10.062","article-title":"Biological activities and potential health benefits of sulfated polysaccharides derived from marine algae","volume":"84","author":"Wijesekara","year":"2011","journal-title":"Carbohydr. Polym."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1002\/fsn3.1835","article-title":"Therapeutic and nutraceutical potentials of a brown seaweed Sargassum fusiforme","volume":"8","author":"Liu","year":"2020","journal-title":"Food Sci. Nutr."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.3390\/md9102106","article-title":"Important determinants for fucoidan bioactivity: A critical review of structure-function relations and extraction methods for fucose-containing sulfated polysaccharides from brown seaweeds","volume":"9","author":"Ale","year":"2011","journal-title":"Mar. Drugs"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Sanjeewa, K.K.A., Herath, K.H., Yang, H.-W., Choi, C.S., and Jeon, Y.-J. (2021). Anti-inflammatory mechanisms of fucoidans to treat inflammatory diseases: A review. Mar. Drugs, 19.","DOI":"10.3390\/md19120678"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"100221","DOI":"10.1016\/j.bcdf.2020.100221","article-title":"Revisit the effects of fucoidan on gut microbiota in health and disease: What do we know and what do we need to know?","volume":"23","author":"Shang","year":"2020","journal-title":"Bioact. Carbohydr. Diet. Fibre"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ijbiomac.2022.07.184","article-title":"Sargassum fusiforme fucoidan ameliorates diet-induced obesity through enhancing thermogenesis of adipose tissues and modulating gut microbiota","volume":"216","author":"Zuo","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"10626","DOI":"10.1021\/acs.jafc.0c02555","article-title":"Sargassum fusiforme fucoidan alleviates high-fat diet-induced obesity and insulin resistance associated with the improvement of hepatic oxidative stress and gut microbiota profile","volume":"68","author":"Zhang","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Jiang, L., Song, C., Ai, C., Wen, C., and Song, S. (2024). Modulation effect of sulfated polysaccharide from Sargassum fusiforme on gut microbiota and their metabolites in vitro fermentation. Front. Nutr., 11.","DOI":"10.3389\/fnut.2024.1400063"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.tox.2009.11.007","article-title":"A 4-week repeated oral dose toxicity study of fucoidan from the Sporophyll of Undaria pinnatifida in Sprague\u2013Dawley rats","volume":"267","author":"Kim","year":"2010","journal-title":"Toxicology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/ptr.3138","article-title":"Toxicological evaluation of fucoidan from Undaria pinnatifidain vitro and in vivo","volume":"24","author":"Chung","year":"2010","journal-title":"Phyther. Res."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Hwang, P.-A., Yan, M.-D., Lin, H.-T.V., Li, K.-L., and Lin, Y.-C. (2016). Toxicological evaluation of low molecular weight fucoidan in vitro and in vivo. Mar. Drugs, 14.","DOI":"10.3390\/md14070121"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Koh, E.-J., Shin, K.-S., Sunwoo, I.Y., Kim, J., and Choi, W.-Y. (2024). Brown seaweed byproduct extracts improve intestinal motility and auto-inflammation in mice with loperamide-induced constipation. Foods, 13.","DOI":"10.3390\/foods13132037"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.regpep.2009.03.012","article-title":"Opioid receptors in the gastrointestinal tract","volume":"155","author":"Holzer","year":"2009","journal-title":"Regul. Pept."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Zhou, X., Chen, Y., Ma, X., Yu, Y., Yu, X., Chen, X., and Suo, H. (2022). Efficacy of Bacillus coagulans BC01 on loperamide hydrochloride-induced constipation model in Kunming mice. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.964257"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Wu, J., Xin, Q., Wang, S., Zhang, X., and Jiang, C. (2025). Aqueous extracts of Elsholtzia ciliata and Hovenia dulcis ameliorate loperamide-induced constipation in mice by promoting intestinal peristalsis and barrier function and the abundance of intestinal beneficial bacteria. Front. Microbiol., 16.","DOI":"10.3389\/fmicb.2025.1531232"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"104414","DOI":"10.1016\/j.fbio.2024.104414","article-title":"Anti-inflammatory activity and structural analysis of fucoidan extracted from Sargassum fusiforme via ESI-TOF MS spectrometry","volume":"60","author":"Je","year":"2024","journal-title":"Food Biosci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.physiol.68.040504.094718","article-title":"Interstitial cells of Cajal as pacemakers in the gastrointestinal tract","volume":"68","author":"Sanders","year":"2006","journal-title":"Annu. Rev. Physiol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Zhu, C., Nie, X., Lu, Q., Bai, Y., and Jiang, Z. (2023). Roles and regulation of Aquaporin-3 in maintaining the gut health: An updated review. Front. Physiol., 14.","DOI":"10.3389\/fphys.2023.1264570"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.12998\/wjcc.v10.i19.6385","article-title":"Intestinal mucosal barrier in functional constipation: Dose it change?","volume":"10","author":"Wang","year":"2022","journal-title":"World J. Clin. Cases"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Tang, T., Wang, J., Jiang, Y., Zhu, X., Zhang, Z., Wang, Y., Shu, X., Deng, Y., and Zhang, F. (2022). Bifidobacterium lactis TY-S01 prevents loperamide-induced constipation by modulating gut microbiota and its metabolites in mice. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.890314"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e71659","DOI":"10.1002\/fsn3.71659","article-title":"The Anti-Constipation Effect of Garlic Polysaccharides: Roles of Gut Barrier Integrity, VIP Pathway, and the Microbiota-SCFAs Axis","volume":"14","author":"Li","year":"2026","journal-title":"Food Sci. Nutr."}],"container-title":["Marine Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-3397\/24\/8\/266\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T13:28:13Z","timestamp":1785504493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-3397\/24\/8\/266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":47,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["md24080266"],"URL":"https:\/\/doi.org\/10.3390\/md24080266","relation":{},"ISSN":["1660-3397"],"issn-type":[{"value":"1660-3397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]}}}